Which class of drug may interact with aldesleukin in a patient with metastatic renal cell carcinoma?
A) Corticosteroids
B) Angiotensin-converting enzyme (ACE) inhibitors
C) Nonsteroidal anti-inflammatory drugs (NSAIDs)
D) Anticoagulants
E) Immunomodulators
